Generic placeholder image

Protein & Peptide Letters

Editor-in-Chief

ISSN (Print): 0929-8665
ISSN (Online): 1875-5305

Research Article

Optimized Expression of Recombinant Human NIMA-Related Kinase 7 (NEK7) with A Higher Purity in Escherichia coli

Author(s): Xing-Jie Zhang, Ting-Ting Wang, Yu-Kun Pu, Lin Zeng, Rui-Han Zhang, Xiao-Li Li, Xu Ji* and Wei-Lie Xiao*

Volume 28, Issue 12, 2021

Published on: 07 December, 2021

Page: [1391 - 1397] Pages: 7

DOI: 10.2174/0929866528666211118092410

Price: $65

conference banner
Abstract

Background: NIMA (never in mitosis, gene A) serine/threonine kinase 7 (NEK7) is a regulator of mitosis spindle in mammals and is considered as a drug target of inflammasome related inflammatory diseases. However, most commercially available or reported recombinant NEK7 proteins are either inactive or have low purity. These shortcomings limit the pharmacological studies and development of NEK7 inhibitors.

Objective: To elucidate what causes the NEK7 low purity in E. coli, and optimize a protocol to improve the protein purity.

Methods: A comparative study of expression full length NEK7 with an N-terminal His-tag or a Cterminal His-tag was performed. His-affinity resin, ion exchange and gel filtration chromatography were used to purify NEK7. The protein was identified by mass spectrometry. The activity and folding of NEK7 were evaluated by chemiluminescent assay and thermal shift assay.

Results: Our results demonstrated that N-terminal tagged protein was toxic to E. coli, resulting in incomplete translated products. The C-terminal tagged NEK7-His6 had a much higher purity than that of an N-terminal tag. The Ni2+ resin one-step purification led to a purity of 91.7%, meeting the criteria of most kinase assays. With two-step and three-step procedures, the protein purities were 94.7% and ~100%, respectively. The NEK7 purified in this work maintained its kinase activity and correct conformation, and the compound-protein interaction ability.

Conclusion: Our optimized protocol could produce good purity of His tagged NEK7 in E. coli, and the kinase activity and biophysical characteristics of which are preserved.

Keywords: NEK7, histidine tag, expression, purification, high purity, kinase.

Graphical Abstract

[1]
Kandli, M.; Feige, E.; Chen, A.; Kilfin, G.; Motro, B. Isolation and characterization of two evolutionarily conserved murine kinases (Nek6 and nek7) related to the fungal mitotic regulator, NIMA. Genomics, 2000, 68(2), 187-196.
[http://dx.doi.org/10.1006/geno.2000.6293] [PMID: 10964517]
[2]
Fry, A.M.; O’Regan, L.; Sabir, S.R.; Bayliss, R. Cell cycle regulation by the NEK family of protein kinases. J. Cell Sci., 2012, 125(Pt 19), 4423-4433.
[http://dx.doi.org/10.1242/jcs.111195] [PMID: 23132929]
[3]
He, Y.; Zeng, M.Y.; Yang, D.; Motro, B.; Núñez, G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature, 2016, 530(7590), 354-357.
[http://dx.doi.org/10.1038/nature16959] [PMID: 26814970]
[4]
He, H.; Jiang, H.; Chen, Y.; Ye, J.; Wang, A.; Wang, C.; Liu, Q.; Liang, G.; Deng, X.; Jiang, W.; Zhou, R. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nat. Commun., 2018, 9(1), 2550.
[http://dx.doi.org/10.1038/s41467-018-04947-6] [PMID: 29959312]
[5]
Martinon, F.; Pétrilli, V.; Mayor, A.; Tardivel, A.; Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature, 2006, 440(7081), 237-241.
[http://dx.doi.org/10.1038/nature04516] [PMID: 16407889]
[6]
Inflammasomes and autoimmune and rheumatic diseases: A comprehensive review. J. Autoimmun., 2019, 103, 102299.
[7]
Sepehri, Z.; Kiani, Z.; Afshari, M.; Kohan, F.; Dalvand, A.; Ghavami, S. Inflammasomes and type 2 diabetes: An updated systematic review. Immunol. Lett., 2017, 192, 97-103.
[http://dx.doi.org/10.1016/j.imlet.2017.10.010] [PMID: 29079203]
[8]
Mangan, M.S.J.; Olhava, E.J.; Roush, W.R.; Seidel, H.M.; Glick, G.D.; Latz, E. Targeting the NLRP3 inflammasome in inflammatory diseases. Nat. Rev. Drug Discov., 2018, 17(8), 588-606.
[http://dx.doi.org/10.1038/nrd.2018.97] [PMID: 30026524]
[9]
Sigma-Aldrich, Nek7, Active human (N4537). 2020. Available from: https://www.sigmaaldrich.com/catalog/product/sigma/n4537?lang=zh&region=CN (Accessed on 16 March 2020).
[10]
Abcam, Recombinant human NEK7 protein (ab196067). 2020. Available from: https://www.abcam.cn/recombinant-human-nek7-protein-ab196067.html (Accessed on 16 March 2020).
[11]
Abcam, Recombinant human NEK7 protein (ab136361). 2020. Available from: https://www.abcam.cn/recombinant-human-nek7-protein-ab136361.html (Accessed on 16 March 2020).
[12]
Daviter, T.; Fronzes, R. Protein sample characterization. In: Protein-Ligand Interactions: Methods and Applications; Williams, M.A.; Daviter, T., Eds.; Humana Press: Totowa, NJ, 2013; pp. 35-62.
[http://dx.doi.org/10.1007/978-1-62703-398-5_2]
[13]
Sharif, H.; Wang, L.; Wang, W.L.; Magupalli, V.G.; Andreeva, L.; Qiao, Q.; Hauenstein, A.V.; Wu, Z.; Núñez, G.; Mao, Y.; Wu, H. Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome. Nature, 2019, 570(7761), 338-343.
[http://dx.doi.org/10.1038/s41586-019-1295-z] [PMID: 31189953]
[14]
Shrestha, A.; Hamilton, G.; O’Neill, E.; Knapp, S.; Elkins, J.M. Analysis of conditions affecting auto-phosphorylation of human kinases during expression in bacteria. Protein Expr. Purif., 2012, 81(1), 136-143.
[http://dx.doi.org/10.1016/j.pep.2011.09.012] [PMID: 21985771]
[15]
Chen, X.; Nomani, A.; Patel, N.; Hatefi, A. Production of low-expressing recombinant cationic biopolymers with high purity. Protein Expr. Purif., 2017, 134, 11-17.
[http://dx.doi.org/10.1016/j.pep.2017.03.012] [PMID: 28315745]
[16]
Simeonov, A. Recent developments in the use of differential scanning fluorometry in protein and small molecule discovery and characterization. Expert Opin. Drug Discov., 2013, 8(9), 1071-1082.
[http://dx.doi.org/10.1517/17460441.2013.806479] [PMID: 23738712]
[17]
Zeng, Q.; Deng, H.; Li, Y.; Fan, T.; Liu, Y.; Tang, S.; Wei, W.; Liu, X.; Guo, X.; Jiang, J.; Wang, Y.; Song, D. Berberine directly targets the NEK7 protein to block the NEK7-NLRP3 interaction and exert anti-inflammatory activity. J. Med. Chem., 2021, 64(1), 768-781.
[http://dx.doi.org/10.1021/acs.jmedchem.0c01743] [PMID: 33440945]
[18]
Xu, J.; Lu, L.; Li, L. NEK7: a novel promising therapy target for NLRP3-related inflammatory diseases. Acta Biochim. Biophys. Sin. (Shanghai), 2016, 48(10), 966-968.
[http://dx.doi.org/10.1093/abbs/gmw080] [PMID: 27563009]
[19]
Bertucci, C.; Piccoli, A.; Pistolozzi, M. Optical biosensors as a tool for early determination of absorption and distribution parameters of lead candidates and drugs. Comb. Chem. High Throughput Screen., 2007, 10(6), 433-440.
[http://dx.doi.org/10.2174/138620707781996411] [PMID: 17896938]
[20]
Grüner, S.; Neeb, M.; Barandun, L.J.; Sielaff, F.; Hohn, C.; Kojima, S.; Steinmetzer, T.; Diederich, F.; Klebe, G. Impact of protein and ligand impurities on ITC-derived protein-ligand thermodynamics. Biochim. Biophys. Acta, 2014, 1840(9), 2843-2850.
[http://dx.doi.org/10.1016/j.bbagen.2014.04.018] [PMID: 24792574]
[21]
Wang, Y.; Wang, G.; Moitessier, N.; Mittermaier, A.K. Enzyme kinetics by isothermal titration calorimetry: allostery, inhibition, and dynamics. Front. Mol. Biosci., 2020, 7, 583826.
[http://dx.doi.org/10.3389/fmolb.2020.583826] [PMID: 33195429]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy